abstracts

P024 Anorectal Manometry in Patients with Fecal Incontinence After Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: A Cohort Study

BACKGROUND: Fecal incontinence (FI) affects up to 1 in 4 patients with inflammatory bowel disease (IBD) and is associated with inflammation, surgeries, and altered rectal sens...

12/15/2021

P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study

BACKGROUND: True North is a phase 3, randomized, double-blind, placebo-controlled trial conducted at 285 sites in 30 countries (NCT02435992). Treatment with on...

12/15/2021

P025 The Impact of Non-Remission on Costs and Resource Use In Patients With Crohn’s Disease: Targeted Literature Review

BACKGROUND: The incidence of Crohn’s disease (CD) has been rising globally. Patients with CD are at an increased risk of mortality compared to general population. The goal of ...

12/15/2021

P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial

BACKGROUND: Ozanimod is an oral sphingosine 1-phosphate (S1P) receptor modulator selectively targeting S1P 1 and S1P ...

12/15/2021

P026 Inflammatory Bowel Disease (IBD) Related Outcomes in Patients Diagnosed With COVID-19

BACKGROUND: Patients with IBD report increased gastrointestinal symptoms, including diarrhea, abdominal pain, and nausea following COVID-19 diagnosis. While there has been a g...

12/15/2021

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

BACKGROUND: Ozanimod, an oral sphingosine 1-phosphate (S1P) receptor modulator that selectively targets S1P 1 and S1P ...

12/15/2021

P027 Brain Fog in Patients With Inflammatory Bowel Disease, and Association With Use of Probiotics

BACKGROUND: Brain fog has been minimally studied in patients with inflammatory bowel disease (IBD). IBD patients frequently consume probiotics, whether sanctioned by a physici...

12/15/2021

P039 IBD Patients’ and Clinicians’ Perceptions of Care Delivery during the COVID-19 Pandemic

BACKGROUND: Both IBD patients and health care professionals (HCPs) are concerned about the effects of the COVID-19 pandemic on care delivery. We seek to determine patient and ...

12/15/2021

P017 Increased Level of Immunoglobulin G in the Development of Adverse Reactions in Patients With Ulcerative Colitis

BACKGROUND: Goal: To identify the relationship between the level of immunoglobulins G and E and the development of adverse reaction (AR) in patients with ulcerative colitis (U...

12/15/2021

P007 The Frequency of Anxiety and Depression in Patients With Inflammatory Bowel Diseases in the Moscow Clinical Scientific Center

BACKGROUND: Anxiety and depression occur in a significant number of patients with inflammatory bowel diseases (IBD). The prevalence of anxiety and / or depression is 13-44.4% ...

12/15/2021

abstracts

Follow Us on Twitter!

Specialties

Events

Year Round Education

HMP Global Products